J&J/CHIRON REGRANEX FOR DIABETIC FOOT ULCERS FEBRUARY LAUNCH WILL STRESS ULCER MANAGEMENT; PLATELET DERIVED GROWTH FACTOR IS FIRST FOR INDICATION
Executive Summary
Ortho-McNeil's February launch of Regranex (becaplermin gel .01%) will include a patient starter kit providing information on the product and details about wound care and diabetic foot ulcer care.